BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24460759)

  • 21. Induction of growth suppression and modification of gene expression in multi-drug-resistant human glioblastoma multiforme cells by recombinant human fibroblast and immune interferon.
    Moulton TA; Jiang H; Guarini L; Fetell MR; Fisher PB
    Int J Cancer; 1992 May; 51(3):373-8. PubMed ID: 1317362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type I interferon receptor-independent interferon-α induction upon infection with a variety of negative-strand RNA viruses.
    Anzaghe M; Kronhart S; Niles MA; Höcker L; Dominguez M; Kochs G; Waibler Z
    J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34269676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
    Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of differential expression of interferon receptor isoforms on the response of multiple sclerosis patients to therapy with interferon beta.
    Gilli F
    J Interferon Cytokine Res; 2010 Oct; 30(10):733-41. PubMed ID: 20874250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand-induced association of the type I interferon receptor components.
    Cohen B; Novick D; Barak S; Rubinstein M
    Mol Cell Biol; 1995 Aug; 15(8):4208-14. PubMed ID: 7623815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity to extrinsically supplied interferon and the endogenous expression of interferon in melanoma cell lines.
    Hanson C; Köpf I; Weijdegård B; Weimarck A; Stierner U
    Melanoma Res; 1999 Oct; 9(5):451-6. PubMed ID: 10596911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.
    Leaman DW; Chawla-Sarkar M; Jacobs B; Vyas K; Sun Y; Ozdemir A; Yi T; Williams BR; Borden EC
    J Interferon Cytokine Res; 2003 Dec; 23(12):745-56. PubMed ID: 14769151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibitory effects of IFN-beta on human liver cancer cells in vitro and in vivo.
    Ogasawara S; Yano H; Momosaki S; Akiba J; Nishida N; Kojiro S; Moriya F; Ishizaki H; Kuratomi K; Kojiro M
    J Interferon Cytokine Res; 2007 Jun; 27(6):507-16. PubMed ID: 17572015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of interferon-alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice.
    Cao B; Chen XP; Zhu P; Ding L; Guan J; Shi ZL
    World J Gastroenterol; 2008 Nov; 14(44):6802-7. PubMed ID: 19058305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.
    Yano H; Ogasawara S; Momosaki S; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Kuratomi K; Basaki Y; Oie S; Kuwano M; Kojiro M
    Liver Int; 2006 Oct; 26(8):964-75. PubMed ID: 16953837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma.
    Furuya N; Kamai T; Shirataki H; Yanai Y; Fukuda T; Mizuno T; Nakamura F; Kambara T; Nakanishi K; Abe H; Yoshida K
    Cancer Immunol Immunother; 2011 Jun; 60(6):793-808. PubMed ID: 21350947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo.
    Takemoto Y; Yano H; Momosaki S; Ogasawara S; Nishida N; Kojiro S; Kamura T; Kojiro M
    Clin Cancer Res; 2004 Nov; 10(21):7418-26. PubMed ID: 15534119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of inducible nitric oxide synthase expression by interferons alpha and beta in bovine retinal pigmented epithelial cells.
    Faure V; Courtois Y; Goureau O
    J Biol Chem; 1997 Dec; 272(51):32169-75. PubMed ID: 9405417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of IFN-alpha2 and IFN-alpha8 exhibits synergistic antiproliferative activity on renal cell carcinoma (RCC) cell lines through increased binding affinity for IFNAR-2.
    Tanimoto T; Yamamoto S; Taniai M; Taniguchi M; Ariyasu H; Ushio C; Aga M; Mukai Y; Tsutsumi Y; Ariyasu T; Ohta T; Fukuda S
    J Interferon Cytokine Res; 2007 Jun; 27(6):517-23. PubMed ID: 17572016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment.
    Aliaga-Gaspar P; Hurtado-Guerrero I; Ciano-Petersen NL; Urbaneja P; Brichette-Mieg I; Reyes V; Rodriguez-Bada JL; Alvarez-Lafuente R; Arroyo R; Quintana E; Ramió-Torrentà L; Alonso A; Leyva L; Fernández O; Oliver-Martos B
    Front Immunol; 2021; 12():778204. PubMed ID: 34975865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses.
    Hwang M; Bergmann CC
    J Virol; 2018 May; 92(10):. PubMed ID: 29491163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis.
    Kamai T; Yanai Y; Arai K; Abe H; Yamanishi T; Kurimoto M; Yoshida K
    BMC Cancer; 2007 Aug; 7():159. PubMed ID: 17697365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.
    Koestner W; Spanier J; Klause T; Tegtmeyer PK; Becker J; Herder V; Borst K; Todt D; Lienenklaus S; Gerhauser I; Detje CN; Geffers R; Langereis MA; Vondran FWR; Yuan Q; van Kuppeveld FJM; Ott M; Staeheli P; Steinmann E; Baumgärtner W; Wacker F; Kalinke U
    PLoS Pathog; 2018 Aug; 14(8):e1007235. PubMed ID: 30075026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-proliferative effect on human pancreatic cancer cells of natural human tumour necrosis factor-beta combined with natural human interferon-alpha or interferon-gamma.
    Watanabe T; Fuchimoto S; Matsubara N; Iwagaki H; Orita K
    J Int Med Res; 1992 Apr; 20(2):112-20. PubMed ID: 1521668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
    Cutrone EC; Langer JA
    J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.